Physician profile
Robert Kelsey
NPI 1043238223
$3,982.79
in general payments reported to CMS, 2019-2025
35 companies · $818 in 2025
The $818 reported for 2025 was more than what 86% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $530 · 2020: $96.35 · 2021: $529 · 2022: $882 · 2023: $520 · 2024: $607 · 2025: $818.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,946.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,946.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,002.40 | 2019-2025 | |
| Coopersurgical, INC. | $383.43 | 2019-2025 | Paragard T 380a, Paragard T 380a, Endosee |
| Organon LLC | $342.08 | 2022-2025 | Nexplanon, Nuvaring, Jada System |
| Avion Pharmaceuticals | $256.99 | 2021-2023 | Balcoltra |
| Hologic Sales and Service, LLC | $225.75 | 2019-2025 | Aptima, Thinprep 2000 Processor, Myosure Tissue Removal Device |
| Merck Sharp & Dohme LLC | $150.33 | 2019-2024 | Gardasil 9, Gardasil |
| Biogen, INC. | $125.03 | 2025 | Zurzuvae |
| Pfizer INC. | $118.70 | 2023-2025 | |
| Exact Sciences Corporation | $108.78 | 2024-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Astellas Pharma US INC | $100.26 | 2024-2025 | Veozah |
| Mayne Pharma Commercial LLC | $99.27 | 2024-2025 | |
| Exeltis, USA INC. | $94.96 | 2024-2025 | Slynd |
| Bayer Healthcare Pharmaceuticals INC. | $85.12 | 2020-2025 | |
| Medtronic, INC. | $84.87 | 2023 | Truclear |
| Allergan, INC. | $84.09 | 2019-2020 |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mylan Pharmaceuticals INC. | $70.62 | 2021-2022 | |
| Millicent US INC | $61.52 | 2025 | Femlyv, Intrarosa |
| Agile Therapeutics, INC. | $51.80 | 2022-2024 | Twirla |
| Dysis Medical, INC. | $49.15 | 2019-2022 | |
| Shield Therapeutics INC | $48.18 | 2023-2025 | Accrufer |
| Therapeuticsmd, INC. | $45.45 | 2019-2021 | |
| Novo Nordisk INC | $43.39 | 2024-2025 | Wegovy |
| Amag Pharmaceuticals, INC. | $42.96 | 2019 | |
| Dexcom, INC. | $34.46 | 2025 | Dexcom G6 Transmitter |
| Vertical Pharmaceuticals, LLC | $33.83 | 2019 | |
| Lupin INC. | $32.21 | 2019 | |
| Boston Scientific Corporation | $29.92 | 2019 | |
| Sumitomo Pharma America, INC. | $26.93 | 2023 | Myfembree |
| Duchesnay USA Incorporated | $26.62 | 2019 | |
| Mission Pharmacal Company | $23.86 | 2019 | |
| Seqirus USA INC | $22.11 | 2024 | Fluad, Flucelvax |
| Myovant Sciences INC. | $21.93 | 2022 | |
| Scynexis, INC. | $21.07 | 2022 | |
| Channel Medsystems, INC. | $18.35 | 2022 | |
| Amgen INC. | $16.37 | 2024 | Prolia, Evenity |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Kelsey listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.